VistaGen Therapeutics
VTGN
VTGN
12 hedge funds and large institutions have $2.68M invested in VistaGen Therapeutics in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
57% less capital invested
Capital invested by funds: $6.27M → $2.68M (-$3.59M)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$69.3K | |
| 2 | +$21K | |
| 3 | +$7.8K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.95K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$14.9K | |
| 3 | -$5.64K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4K |